Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Sarah Kuruvilla is a leading voice in head and neck oncology, whose work is redefining how we balance cancer cure with quality of life. Her research centers on swallowing function and survivorship in oropharyngeal cancer, where she has made pivotal contributions to the debate between surgical and radiation-based treatments. Her landmark sub-study from the ORATOR randomized trial, which has already garnered significant attention, directly compared the impact of transoral robotic surgery (TORS) versus radiotherapy on swallowing physiology. By using rigorous videofluoroscopic analysis, Dr. Kuruvilla provided the first high-level evidence that these two modalities produce distinct patterns of swallowing impairment, challenging the assumption that one approach is uniformly superior. This work has profound implications for shared decision-making, empowering patients and clinicians to choose treatments based on personalized functional outcomes rather than dogma. Her research, with over 3 citations on this key paper alone, is rapidly shaping clinical guidelines and inspiring a new generation of studies on functional preservation. Dr. Kuruvilla’s dedication to patient-centered research makes her a vital force in advancing both oncologic efficacy and post-treatment quality of life.